Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KZ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.36ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JQ.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KT.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LA.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LH.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LN.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.25.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.16.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.57.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.44.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.1.6.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GY.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCWENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GA.2.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.3.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.21ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.36ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
XBB.1.5.108ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JS.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
XBB.1.5.104ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HH.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GA.4.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GW.5.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
JE.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.7.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
XBB.1.16.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GN.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JH.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GJ.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GJ.1.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HN.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
EG.10.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
XBB.1.41.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GW.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JG.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.24.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.1.8.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GE.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GA.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
HK.3.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.13.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used